If any of these occur, seek medical care right away
Xu D, Nair A, Sigston C, Ho C, Li J, Yang D et al (2022) Potential roles of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in nondiabetic populations
Diabetes Care 1998: 21: 165963
The companies that worked on this, then, in the 70s, the 80s, included Lilly and Novo, actually, but it wasnt until the Gila monster story kicked in in the late 80sI think this guy named John Eng in the Bronx was interested in why certain animals didnt need to eat very often and identified this mimic of the human peptide, but used for this lizards own purposes, exendin, which mimics GLP-1
Counsel patients regarding the potential risk of MTC and the symptoms of thyroid tumors (4, 5.1, 13.1)